David Bailey Buys 55,115 Shares of KindlyMD (NASDAQ:NAKA) Stock

KindlyMD, Inc. (NASDAQ:NAKA) CEO David Bailey acquired 55,115 shares of KindlyMD stock in a transaction dated Thursday, May 28th. The shares were bought at an average cost of $5.62 per share, with a total value of $309,746.30. Following the transaction, the chief executive officer owned 3,175,476 shares in the company, valued at approximately $17,846,175.12. This trade represents a 1.77% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

KindlyMD Stock Up 11.8%

Shares of NAKA stock opened at $6.26 on Friday. The company has a market cap of $108.92 million, a price-to-earnings ratio of -0.14 and a beta of 17.12. KindlyMD, Inc. has a 52 week low of $4.50 and a 52 week high of $995.60. The firm has a 50 day moving average of $8.14 and a 200-day moving average of $13.02.

KindlyMD (NASDAQ:NAKA) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($15.20) EPS for the quarter. The company had revenue of $2.68 million for the quarter. KindlyMD had a negative return on equity of 81.32% and a negative net margin of 7,397.12%. Analysts anticipate that KindlyMD, Inc. will post -16.8 earnings per share for the current year.

KindlyMD News Roundup

Here are the key news stories impacting KindlyMD this week:

• Positive Sentiment: CEO David Bailey bought 31,500 more shares at $5.58, adding to a recent series of insider purchases that may reassure investors about the company’s outlook. Article Title
• Positive Sentiment: Maxim Group reiterated a Buy rating on NAKA with a $30 price target, and its newer earnings forecasts imply a possible improvement in results over time. Article Title
• Neutral Sentiment: The analyst estimates still call for losses in the next several quarters, though they show a potential path toward profitability in fiscal 2027. Article Title
• Negative Sentiment: KindlyMD’s latest reported quarter showed a large EPS loss and very weak profitability, underscoring that the business remains highly speculative despite the recent stock strength. Article Title

Hedge Funds Weigh In On KindlyMD

A number of large investors have recently modified their holdings of NAKA. Geode Capital Management LLC lifted its holdings in shares of KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after purchasing an additional 8,386 shares in the last quarter. Osaic Holdings Inc. bought a new position in shares of KindlyMD in the 2nd quarter worth $215,000. Truist Financial Corp bought a new position in shares of KindlyMD in the 3rd quarter worth $12,470,000. Correct Capital Wealth Management bought a new position in shares of KindlyMD in the 3rd quarter worth $111,339,000. Finally, RFG Advisory LLC bought a new position in shares of KindlyMD in the 3rd quarter worth $1,019,000.

Analyst Ratings Changes

Several analysts have recently commented on NAKA shares. B. Riley Financial reduced their price objective on shares of KindlyMD from $40.00 to $20.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. TD Cowen initiated coverage on shares of KindlyMD in a research report on Friday, April 10th. They set a “buy” rating and a $40.00 price objective for the company. Wall Street Zen upgraded KindlyMD to a “sell” rating in a report on Saturday, May 23rd. Maxim Group cut their target price on KindlyMD from $60.00 to $30.00 and set a “buy” rating on the stock in a report on Monday, April 6th. Finally, Weiss Ratings upgraded KindlyMD from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 11th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $30.00.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.